A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs. - Wikidata - wikimedia - TriplyDB

A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

http://www.wikidata.org/entity/Q37535105

about

Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks Cholera Toxin Subunit B as Adjuvant--An Accelerator in Protective Immunity and a Break in Autoimmunity Is there a role for plant-made vaccines in the prevention of HIV/AIDS?Recombinant expression, purification, and biophysical characterization of the transmembrane and membrane proximal domains of HIV-1 gp41.Expression of HIV-1 antigens in plants as potential subunit vaccines Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitope HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis.Targeting Trojan Horse leukocytes for HIV prevention.Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection Expression, purification and crystallization of CTB-MPR, a candidate mucosal vaccine component against HIV-1.Plant-based vaccines against viruses.N-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential.Humoral immunogenicity of an HIV-1 envelope residue 649-684 membrane-proximal region peptide fused to the plague antigen F1-V.Cholera toxin B: one subunit with many pharmaceutical applications.Mother-to-Child HIV-1 Transmission Events Are Differentially Impacted by Breast Milk and Its Components from HIV-1-Infected Women.Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles.Bacterial expression, correct membrane targeting and functional folding of the HIV-1 membrane protein Vpu using a periplasmic signal peptide Intranasal delivery of vaccines against HIV.Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity.Biological and biochemical characterization of HIV-1 Gag/dgp41 virus-like particles expressed in Nicotiana benthamiana GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium.HIV/AIDS vaccines: a need for new concepts?Transcytosis-blocking abs elicited by an oligomeric immunogen based on the membrane proximal region of HIV-1 gp41 target non-neutralizing epitopes.Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case study In planta production of plant-derived and non-plant-derived adjuvants.Development of plant-based mucosal vaccines against widespread infectious diseases.Current status and perspectives of plant-based candidate vaccines against the human immunodeficiency virus (HIV).N-Glycosylation of Cholera Toxin B Subunit: Serendipity for Novel Plant-Made Vaccines?A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.Utilization of cholera toxin B as a mucosal adjuvant elicits antibody-mediated protection against S. pneumoniae infection in mice.The Cholera Toxin B Subunit (CTB) Fused to the Porcine Arterivirus Matrix M and GP5 Envelope Proteins Fails to Enhance the GP5-Specific Antibody Response in Pigs Immunized with Adenovectors.A Plant-Derived Multi-HIV Antigen Induces Broad Immune Responses in Orally Immunized Mice.A chloroplast-derived C4V3 polypeptide from the human immunodeficiency virus (HIV) is orally immunogenic in mice.

P2860

Q21090119-CDF4C560-E5E9-4447-8775-B59293D1CED8 Q26782576-CD654944-E434-4BFC-A32F-41CDB242F2AD Q30350670-5AE045D1-A641-4992-A26C-78480F02EB89 Q30601090-B6F61E14-4CC2-4D3F-871C-152DBD4059AC Q33345905-666E292A-40DA-4410-970B-CF5EDF1E834F Q33417195-576EDD2D-223B-4122-9AD6-FA56143BE2ED Q33479955-71C49361-99EF-4050-BA60-B182D7451146 Q33518390-EA1BFEE3-5CAA-4422-9ACF-A667E001A4E5 Q33575368-34DE03A6-B8EA-40CA-A510-26DD07908A02 Q34242643-E82257C9-4D29-4DB3-AAE5-745505DD8D40 Q34687464-1AE76F21-FACC-46C5-9047-EA8F73F7D36D Q35003962-47FBD523-E16B-4D5C-B588-D0E887A9E53D Q35153426-6B50D19B-A81C-49FC-9B65-912DB824DE4C Q35232735-06FFF701-E2D7-4515-875A-5566D112185C Q35872338-17B84D7C-B965-4E51-994E-902131FCD331 Q35960908-9584EAE3-BA6A-4FC2-9678-FD5CA23985FB Q36287480-BA764792-BB0D-4F2D-995D-C19B5C0F3272 Q36409054-BC0506A4-0477-4CC4-B27C-ADCB5771D6DF Q36427185-323DECC6-69F8-4889-B98F-BFF224AD652E Q36497712-A994652B-32E4-492B-BABF-ABCBD0CD865A Q36780136-519CAEA6-EE1A-4B4D-AD7D-AFFAF181ADB8 Q36944911-30644C16-D43B-472E-9A25-4CA88D7E29BF Q37063527-2560FF72-8369-4443-8B71-48F18AB1265A Q37344236-4421B104-A8E9-4A46-88B9-ED9C280D4623 Q37348636-14F2E68D-EA98-42FA-B958-684C338E2575 Q37377681-05B583B2-7908-4EDC-A821-64453E3C2C30 Q37776716-90A123D8-A900-47E9-8CCF-9BB33034C900 Q37776721-17D70DBB-53EF-4BA4-B778-C9A798D1E82B Q37967232-AFCB80CD-0C07-4316-B481-4F83BC31FE05 Q40143890-C9D35EB7-81B4-4561-AD21-4AEB8308A4E1 Q40220988-AD177D76-B7D6-4E2C-B8A4-DE76978A314F Q40277871-3B75CC0E-33F2-4925-AC11-DC63A0C5AD2B Q41392262-ACE1F48D-F368-4963-849D-8EE8D741C84F Q41424896-11C1EABF-0A6A-4DFA-9B7D-C9E951F4DEA6 Q43894830-AF6DB553-E8D3-4C56-8F96-914F0CB1C44B

P2860

A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

http://www.wikidata.org/entity/Q37535105

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 September 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

@en

A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

@nl

type

label

A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

@en

A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

@nl

prefLabel

A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

@en

A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

@nl

P1433

Q37535105-4E3DB77D-EAEE-4A96-A4E0-3CD8CDA0C2EF

P1476

Q37535105-E8721ED4-C9F3-4889-B6C6-20E2F912A919

P2093

Q37535105-48CF1123-C3FC-4FAA-A7D1-73BF6A179980

Q37535105-6576CF6B-DA34-4179-BB36-266314F42DF5

Q37535105-90CA9984-EEDD-4A07-BC32-1245DF74DD47

Q37535105-C5B33553-C480-4A30-92C6-58B3F7C3BCFB

Q37535105-CA9A7441-73A0-4176-BB2F-82860293850A

Q37535105-FAD6C296-52BB-4C24-80C4-F364996A400C

P2860

Q37535105-00144CDD-012C-473B-AFF5-3048B4215DC0

Q37535105-0296BCF3-DB68-40CF-95A4-05A74DF832F0

Q37535105-0B0E5E15-48AE-439A-85D5-A369FF4A7265

Q37535105-0E87DAA7-BFD4-44DE-BBC7-348447EAA66B

Q37535105-250F02EC-4DFC-4458-834C-509615B2D04B

Q37535105-257BA146-6AD2-4700-AAB1-755B4B70F864

Q37535105-26D0DD96-A2E1-470D-B1E4-0BE4C15328E6

Q37535105-337B75E0-F7F6-4D9E-B386-AA8D999A7EFF

Q37535105-379A01BD-7FD8-48AC-AC63-7D2FE778461D

Q37535105-38B69647-EEF6-4BB3-BFD0-4EEDCD4DDC0C

P304

Q37535105-19CF3051-F38B-4613-88AE-624D6923776D

P31

Q37535105-FE2E5B05-E617-4568-94F9-71969ED45482

P356

Q37535105-55D5CF37-139A-43AE-99EE-8100E48D8C5B

P407

Q37535105-8E836ECF-B4CA-4A52-A88E-00E4B7F5BBFE

P433

Q37535105-DED197F8-EAC1-4304-BE79-C5E09BB739E3

P478

Q37535105-7C1DA952-7F3F-4DA4-9669-92C08ED6935F

P50

Q37535105-23836F13-0698-4AC2-84E6-0E079F9F5AD9

Q37535105-33F93F3F-AE1D-45D3-93C3-E0044B05FAC6

Q37535105-35928F15-7B35-47BB-9F99-0CAD70B3147A

P577

Q37535105-20EFE0B7-FA70-405E-B68C-758F6C22457C

P5875

Q37535105-125A8EF2-B2E8-4872-8551-277F6EBBC186

P698

Q37535105-D5E7CB8C-6554-4414-BE66-21FB7F01E4A5

P921

Q37535105-B18F8016-4313-4AC2-A0BC-DE44029782EC

P932

Q37535105-13BEDB8B-5A1E-4CC5-8029-C3EEBD0CA10A

P356

PNAS.0405297101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs

@en

P2093

Annette Alfsen

http://www.w3.org/2001/XMLSchema#string

Brian C Geyer

http://www.w3.org/2001/XMLSchema#string

Charles J Arntzen

http://www.w3.org/2001/XMLSchema#string

Mrinalini Muralidharan

http://www.w3.org/2001/XMLSchema#string

Tsafrir S Mor

http://www.w3.org/2001/XMLSchema#string

Yunfang Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

Transmission, acute HIV-1 infection and the quest for strategies to prevent infection

Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein

Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

Regional specialization in the mucosal immune system: primed cells do not always home along the same track.

Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1.

Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells.

Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its vlosely related homologue, the B subunit of cholera toxin.

P304

13584-13589

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0405297101

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Aude Magerus-Chatinet

Nobuyuki Matoba

P577

2004-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8365171

http://www.w3.org/2001/XMLSchema#string

P698

15347807

http://www.w3.org/2001/XMLSchema#string

P921

P932

518798

http://www.w3.org/2001/XMLSchema#string